Viatris Inc
Close on Nov 18, 2026Market cap $23.29BP/E –Yield 2.37%
Viatris Products in Active Development by Year
Products in Active Development — Developed Markets
Viatris Products in Active Development: 150 in FY2025, unchanged from a year earlier.
Where the FY2025 figure comes from
“Developed Markets 200 150 ~150”
Source: Viatris 2025 Sustainability Report ↗
Unique molecule + dosage form programs in active development by commercial segment.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Products in Active Development — Developed Markets | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 150 | 0.0% | Viatris 2025 Sustainability Report ↗ |
| FY2024 | Dec 31, 2024 | 150 | -25.0% | Viatris 2025 Sustainability Report ↗ |
| FY2023 | Dec 31, 2023 | 200 | 0.0% | Viatris 2025 Sustainability Report ↗ |
| FY2022 | Dec 31, 2022 | 200 | -4.8% | Viatris 2024 Sustainability Report ↗ |
| FY2021 | Dec 31, 2021 | 210 | +16.7% | Viatris 2023 Sustainability Report ↗ |
| FY2020 | Dec 31, 2020 | 180 | – | Viatris 2023 Sustainability Report ↗ |
Breakdown
What makes up products in Active Development
Cite this data
StockData. (2026). Viatris Products in Active Development, annual FY2020–FY2025 [Data set]. Compiled from Viatris SEC filings and investor materials. https://stockdatahq.com/stocks/vtrs/kpis/prod-dev-dm
See every metric in the Viatris KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?